AAAAAA
Results:
1-11
|
Results: 11
Authors:
CHURCHILL AJ
FRANKS WA
ASH DV
Citation: Aj. Churchill et al., AN ALTERNATIVE AND MORE COST-EFFECTIVE METHOD OF DELIVERY OF RADIOTHERAPY IN AGE-RELATED MACULAR DEGENERATION, British journal of ophthalmology, 82(4), 1998, pp. 373-375
Authors:
SETHI T
DIXON B
FLYNN A
ASH DV
Citation: T. Sethi et al., CONTINUOUS, PULSED OR SINGLE ACUTE IRRADIATION OF A TRANSPLANTED RODENT TUMOR-MODEL, Radiotherapy and oncology, 43(2), 1997, pp. 203-209
Authors:
STABLES GI
STRINGER MR
ROBINSON DJ
ASH DV
Citation: Gi. Stables et al., LARGE PATCHES OF BOWENS-DISEASE TREATED BY TOPICAL AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY, British journal of dermatology, 136(6), 1997, pp. 957-960
Authors:
SETHI T
ASH DV
FLYNN A
WORKMAN G
Citation: T. Sethi et al., REPLACEMENT OF HAIRPIN AND LOOP IMPLANTS BY OPTIMIZED STRAIGHT-LINE SOURCES, Radiotherapy and oncology, 39(2), 1996, pp. 117-121
Authors:
STABLES GI
ASH DV
Citation: Gi. Stables et Dv. Ash, PHOTODYNAMIC THERAPY, Cancer treatment reviews, 21(4), 1995, pp. 311-323
Authors:
HUDSON EJ
STRINGER MR
CAIRNDUFF F
ASH DV
SMITH MA
Citation: Ej. Hudson et al., THE OPTICAL-PROPERTIES OF SKIN TUMORS MEASURED DURING SUPERFICIAL PHOTODYNAMIC THERAPY, Lasers in medical science, 9(2), 1994, pp. 99-103
Authors:
CAIRNDUFF F
STRINGER MR
HUDSON EJ
ASH DV
BROWN SB
Citation: F. Cairnduff et al., SUPERFICIAL PHOTODYNAMIC THERAPY WITH TOPICAL 5-AMINOLEVULINIC ACID FOR SUPERFICIAL PRIMARY AND SECONDARY SKIN-CANCER, British Journal of Cancer, 69(3), 1994, pp. 605-608
Authors:
ASH DV
BROWN SB
Citation: Dv. Ash et Sb. Brown, NEW DRUGS AND FUTURE-DEVELOPMENTS IN PHOTODYNAMIC THERAPY, European journal of cancer, 29A(12), 1993, pp. 1781-1783
Authors:
BLEEHEN NM
GIRLING DJ
MACHIN D
STEPHENS RJ
BARLEY VL
BULLIMORE JA
WHITE RJ
BLEEHAN NM
WILLIAMS MV
BREDIN CP
DAVIDSON AR
WILLIAMS TJ
ASH DV
CLOSE HJ
JOSLIN CA
MUERS MF
STONE J
ASHFORD RF
DISCHE S
DUNPHY EP
FERMONT DC
GROSCH E
MAHER EJ
SAUNDERS MI
ADAM RJ
ALCOCK CJ
BENSON MK
HOPKIN JM
LANE DJ
HUNTER AM
Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS, British Journal of Cancer, 68(6), 1993, pp. 1150-1156
Authors:
BLEEHEN NM
GIRLING DJ
MACHIN D
STEPHENS RJ
HARTLEY JPR
HODSON NJ
TURTON CW
BARLEY VL
BULLIMORE JA
WHITE RJ
BLEEHEN NM
WILLIAMS MV
BREDIN CP
DAVIDSON AR
WILLIAMS TJ
ASH DV
CLOSE HJ
JOSLIN CA
MUERS MF
STONE J
ASHFORD RF
DISCHE S
DUNPHY EP
FERMONT DC
GROSCH E
MAHER EJ
SAUNDERS MI
ADAM RJ
ALCOCK CJ
BENSON MK
HOPKIN JM
LANE DJ
HUNTER AM
Citation: Nm. Bleehen et al., A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE, British Journal of Cancer, 68(6), 1993, pp. 1157-1166
Authors:
LOWDELL CP
ASH DV
DRIVER I
BROWN SB
Citation: Cp. Lowdell et al., INTERSTITIAL PHOTODYNAMIC THERAPY - CLINICAL-EXPERIENCE WITH DIFFUSING FIBERS IN THE TREATMENT OF CUTANEOUS AND SUBCUTANEOUS TUMORS, British Journal of Cancer, 67(6), 1993, pp. 1398-1403
Risultati:
1-11
|